United States · Series C startup
Funding summaryUpdated 26 Oct 2026
$68Mraised across 3 rounds since 2018, from 4 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by U.S. Venture Partners and 1 otherSEC filing: $24M sold
Source recorded
Reported by FinSMEsSEC filing: $3.0M sold, first sale Jul 2017
From Cagent Vascular's own website: 1 founder, 6 on the team.
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Ben Franklin Technology Partners of Southeastern Pennsylvania
Ben Franklin Technology Partners
BalestierSynergyMissing a round, or an investor who was in one? Tell us.
This firm lists Cagent Vascular as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.
Cagent Vascular's investors include Trinity Capital, Ben Franklin Technology Partners of Southeastern Pennsylvania, Ben Franklin Technology Partners, Balestier and Synergy.
Cagent Vascular has raised $68M across 3 rounds since 2018.
Cagent Vascular's most recent round was a Series C of $41M in May 2026.
Its most recent round, $41M in May 2026, is also its largest on record.
Cagent Vascular's first round on record, in Jul 2018, was backed by Ben Franklin Technology Partners, Balestier and Synergy.
Cagent Vascular's latest named round is a Series C, in May 2026.
Cagent Vascular is based in the United States.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
